TrialJournal of Parkinson's disease2022

Safety, Pharmacokinetics, and Pharmacodynamics of Oral Venglustat in Patients with Parkinson's Disease and a GBA Mutation: Results from Part 1 of the Randomized, Double-Blinded, Placebo-Controlled MOVES-PD Trial.

M Judith Peterschmitt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.